Mesoblast (MESO) Operating Expenses: 2014-2024
Historic Operating Expenses for Mesoblast (MESO) over the last 9 years, with Dec 2024 value amounting to -$10.5 million.
- Mesoblast's Operating Expenses fell 13.72% to -$10.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $35.0 million, marking a year-over-year increase of 49.48%. This contributed to the annual value of $74.1 million for FY2025, which is 35.09% up from last year.
- Per Mesoblast's latest filing, its Operating Expenses stood at -$10.5 million for Q4 2024, which was down 6.57% from -$9.8 million recorded in Q2 2024.
- Mesoblast's 5-year Operating Expenses high stood at $92.2 million for Q2 2021, and its period low was -$21.1 million during Q1 2020.
- Over the past 3 years, Mesoblast's median Operating Expenses value was -$10.5 million (recorded in 2024), while the average stood at $2.8 million.
- Over the last 5 years, Mesoblast's Operating Expenses had its largest YoY gain of 1,468.63% in 2021, and its largest YoY loss of 130.08% in 2021.
- Over the past 5 years, Mesoblast's Operating Expenses (Quarterly) stood at -$21.0 million in 2020, then climbed by 13.15% to -$18.2 million in 2021, then climbed by 10.95% to -$16.2 million in 2022, then surged by 43.20% to -$9.2 million in 2023, then decreased by 13.72% to -$10.5 million in 2024.
- Its last three reported values are -$10.5 million in Q4 2024, -$9.8 million for Q2 2024, and -$9.2 million during Q4 2023.